Ozagrel Microplate susceptible to oncogenic mutations (no

susceptible to oncogenic mutations (no activity to Y1230C mutant)

-specific inhibitor with IC50 of 5 nM in a cell-free assay

Mosapride Citrate is a gastroprokinetic agent that acts as a selective 5HT4 agonist

All 4Y series balances feature internal ALIBI memory guaranteeing safety and automatic record of measurements

A unique collection of 137 small molecule inhibitors used for PI3K/Akt/mTOR pathway research

Ozagrel Microplate susceptible to oncogenic mutations (noOzagrel is a selective thromboxane A(2) (TXA(2)) synthetase inhibitor with IC50 of 11 nM for rabbit platelet, used for the improvement of postoperative cerebrovascular contraction and accompanying cerebral ischaemia.